A refractory composition including refractory aggregate, one or more matrix components, and silicate-coated set accelerator particles. The silicate-coated set accelerator particles can include one more of silicate-coated calcium hydroxide, magnesium hydroxide, calcium chloride, calcium carbonate, magnesium carbonate and calcium sulfate. Suitable silicate coatings include sodium silicate, potassium silicate, lithium silicate and mixtures thereof. A method of recovering an aged refractory composition, a settable composition and a method of manufacturing silicate-coated calcium hydroxide particles are also provided.

Disclosed herein are methods for treating wastewater grit to inactivate any pathogens that are present in the grit and for forming a solidified material comprising wastewater grit such as a chemically bonded phosphate ceramic (CBPC). The CBPC may be utilized in methods for repairing depressions in a road surface that include applying the uncured CBPC to the depression in the road surface and allowing the CBPC to cure.

Disclosed herein are methods for treating wastewater grit to inactivate any pathogens that are present in the grit and for forming a solidified material comprising wastewater grit such as a chemically bonded phosphate ceramic (CBPC). The CBPC may be utilized in methods for repairing depressions in a road surface that include applying the uncured CBPC to the depression in the road surface and allowing the CBPC to cure.

The present invention relates generally to silicate-based coatings and to methods to make and apply same. In one embodiment, the silicate-coatings of the present invention are formed from a two part mixture of phosphate-based component and a glass-based component. In another embodiment, the silicate-based coatings of the present invention are free from any organic materials.

A use of a thiosulfate as a retarder for a cement paste comprising a magnesium phosphate cement.

A use of a thiosulfate as a retarder for a cement paste comprising a magnesium phosphate cement.

A use of a thiosulfate as a retarder for a cement paste comprising a magnesium phosphate cement.

The present provides a concrete and mortar mix and composition thereof with poor quality sand such as desert sand, hydraulic binder (cement) and filamentous cellulose, where the desert sand/spherical sand replaces conventional concrete river sands. The present disclosure also relates a filamentous cellulose, such as, cellulose filaments (CF), cellulose nano filaments, cellulose nanofibrils (CNF) and microfibrillated cellulose (MFC) as a concrete/mortar and sand adhesion additive with hydraulic binder (cement), and to a method of making the concrete. This method also relates to a method to prevent the sliding of individual sand grains against one another and therefor similarly contributes to the stabilization of the building materials.

The present disclosure relates to a bio-material composition comprising a dry potassium phosphate based mixture omprising: MgO, monobasic potassium phosphate, monobasic sodium phosphate, proteoglycans, calcium sodium phosphosilicate, and an antibiotic, wherein a weight percent ratio of monobasic potassium phosphate to MgO is between about 3:1 and 1:1, wherein the dry otassium phosphate based mixture is configured to be mixed with the aqueous solution to thereby form a reabsorbable bio-material slurry, wherein the proteoglycans are between about 1-10 weight percent of the dry composition, and wherein the proteoglycans act as active regulators of collagen fibrillogenesis to thereby structure tissue of a patient by organizing a bone extracellular matrix.

The present disclosure relates to a bio-material composition comprising a dry potassium phosphate based mixture omprising: MgO, monobasic potassium phosphate, monobasic sodium phosphate, proteoglycans, calcium sodium phosphosilicate, and an antibiotic, wherein a weight percent ratio of monobasic potassium phosphate to MgO is between about 3:1 and 1:1, wherein the dry otassium phosphate based mixture is configured to be mixed with the aqueous solution to thereby form a reabsorbable bio-material slurry, wherein the proteoglycans are between about 1-10 weight percent of the dry composition, and wherein the proteoglycans act as active regulators of collagen fibrillogenesis to thereby structure tissue of a patient by organizing a bone extracellular matrix.